VGX-1027
VGX-1027 is an orally active immunomodulatory agent that primarily targets macrophages, it can inhibit TNF-α secretion via interference of macrophage toll-like receptor (TLR) 4 and TLR 2/6 signaling pathway. VGX-1027 also reduces the secretion of pro-inflammatory cytokines IL1-β, IL-10 and IFN-γ.
| Trivial name | GIT 27 |
| Catalog Number | CSN15856 |
| Alternative Name(s) | GIT 27 |
| Research Area | Immunology/Inflammation |
| Molecular Formula | C11H11NO3 |
| CAS# | 6501-72-0 |
| Purity | ≥99% |
| SMILES | O=C(O)CC1CC(C2=CC=CC=C2)=NO1 |
| Size | 25mg |
| Supplier Page | https://www.csnpharm.com/products/vgx-1027.html |